摘要 |
Molecular assays that involve measurement of expression levels of prognostic biomarkers, or co-expressed biomarkers, from a biological sample obtained from a prostate cancer patient, and analysis of the measured expression levels to provide information concerning the likely prognosis for said patient, and likelihood that said patient will have a recurrence of prostate cancer, or to classify the tumor by likelihood of clinical outcome or TMPRSS2 fusion status, are provided herein. |
申请人 |
GENOMIC HEALTH, INC. |
发明人 |
SHAK, STEVEN;BAEHNER, FREDERICK, L.;MADDALA, TARA;LEE, MARK;PELHAM, ROBERT, J.;COWENS, WAYNE;CHERBAVAZ, DIANA;KIEFER, MICHAEL, C.;CRAGER, MICHAEL;GODDARD, AUDREY;BAKER, JOFFRE, B. |